Perspective Therapeutics CATX
NYSE CATX
$2.76 +0.04 (+1.47%)
As of: Oct 2, 2026 · 1:05 PM EDT

Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022)

Updated

Perspective Therapeutics (CATX) recorded Liabilities from Discontinued Operations of $331,000 in Q4 2022.

Analysis

Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Perspective Therapeutics 312.60 Mn 312.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 331,000.00
API Access

Perspective Therapeutics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=CATX&period=max&api_key=YOUR_API_KEY